MaxWell Clinic is recruiting a committed cohort of Alzheimer’s patients for a trial to evaluate plasmapheresis and how it may benefit those with Alzheimer’s disease or cognitive impairment.
Plasmapheresis is an FDA-approved procedure for more than 50 indications and it has been shown to improve a range of health measures. A previous trial, called The AMBAR study, was designed to evaluate whether the progression of Alzheimer’s could be stabilized through therapeutic plasma exchange. The results showed a reduced disease progression in patients with mild-to-moderate Alzheimer’s, as well as a reduction in decline in memory, orientation, and judgment. Our trial at MaxWell Clinic will continue to research this life-changing therapy.
As you get older, your blood becomes polluted with “rusty” proteins and “sticky” molecules that may adversely affect your brain and body. By “rusty” we mean damaged by oxygen, and by “sticky” we mean damaged in a way to stimulate the immune system and cause inflammation. Since your blood is the river of nourishment for your cells, your cells’ health is influenced by the health of your blood.
Therapeutic Plasma Exchange helps to clean your blood and removes certain harmful substances circulating in your plasma.
This innovative therapy has the potential to slow down the rate of brain and body degeneration.
All participants will receive one Plasma Exchange at no cost. Through participation, you will also contribute to the advancement of human knowledge and the development of life-improving therapeutics!
This study aims to understand plasmapheresis effects in committed volunteers who are currently in various stages of Alzheimer’s. The treatment and follow-up visits require a totla of 5 visits to MaxWell Clinic over the course of 28 days. Participants will undergo 1 Therapeutic Plasma exchange and then have blood drawn on days 7, 14, 21 and 28. Once the final blood sample is collected on day 28 that marks the completion of the participant’s involvement.
Participants must have good veins and not be afraid of needles.
Find out if you qualify to participate
Please call our Clinical Research Coordinator at 615-370-0091, ext 1172, or schedule a call below.